Home » Topics » Disease categories and therapies » Immune

Immune
RSS

FK-778 reduces expression of adhesion molecules in preclinical models of allograft rejection

April 30, 2004

MedImmune to reacquire rights to FluMist and CAIV-T from Wyeth

April 29, 2004

ABI-793 shows promise, complications in renal transplant model

April 28, 2004

Dynport completes preclinical testing of recombinant plague vaccine

April 23, 2004

Adenosine deaminase inhibitors effective against inflammation and leukemia in vivo

April 23, 2004

Roche and Isotechnika restructure ISA-247 collaboration agreement

April 22, 2004

Celltech patent covers novel IMPDH inhibitors and their use

April 16, 2004

Cytos' second Immunodrug platform enters clinical development

April 15, 2004

Acambis suspends enrollment in ACAM-2000 phase III trials

April 15, 2004

DynPort develops tularemia vaccine under NIAID award

April 7, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...